Minglin Ma
The TRAFFIC is an implantable and retrievable device that has the potential to revolutionize the way patients with T1D manage their disease. The Ignite funding allowed the group to collect necessary in vivo data.
Key outcome: $6.4M in sponsored research effort from Novo Nordisk
